The present invention includes compositions, methods and systems to
isolate and characterize novel antiviral agents by contacting the
antiviral agent with the F2F3 zinc fingers of a CPSF30 protein and an
Influenza A NS1A protein; and determining whether the binding between the
CPSF30 protein and the Influenza A NS1A protein is reduced.